Both iMGL‐ and hNSC‐derived EVs significantly reduced amyloid beta plaques, astrogliosis, and microglial activation, while restoring synaptophysin and postsynaptic density protein PSD‐95 to control levels in AD brains. The gene discussed is SYP; the disease is Alzheimer disease.